series-c-plus
Stage
2018
Founded
1
Investors
About
Accession Therapeutics is a biotechnology company focusing on the development of new therapeutic options for cancer treatment.
Explore Accession Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.